Biocon Biologics  /  About Us  /  Executive Leadership Team

EXECUTIVE LEADERSHIP TEAM

At Biocon Biologics, the vast experience and the strategic focus of the Executive Leadership Team (ELT) steer us towards our goals. The ELT brings together seasoned professionals with various functional expertise such as Finance, Sales, Marketing, Manufacturing, R&D, Operations, Human Resources, Quality, Communications and Legal. The ELT articulates BBL’s purpose, sets a clear and actionable strategy for achieving that purpose, and most importantly, motivates and empowers everyone else in the organization to succeed. It also executes its role in corporate governance through regular reviews of our financial performance and critical business issues.

Shreehas Tambe

SHREEHAS P TAMBE

Chief Executive Officer

and Managing Director

CHINAPPA M.B.

Chief Financial Officer

DR. ANUJ GOEL

Chief Scientific Officer

DR. SANDEEP N. ATHALYE

Chief Medical

Officer

SUSHEEL UMESH

Chief Commercial

Officer – Emerging

Markets

MATTHEW ERICK

Chief Commercial Officer

Advanced Markets

PAUL VAZHAYIL THOMAS

Global Head – Portfolio

and Program Management

Ganesh Reddy

GANESH REDDY

Global Head of

Manufacturing

KIRAN KUMAR

Site Head,

Biocon Malaysia

MICHAEL CUTTER

Chief Quality Officer

SEEMA AHUJA

Global Head of

Corporate Brand & Head

of Communications – EMs

Stephanie Wasco

STEPHANIE WASCO

Head of Communications

– Advanced Markets

AKHILESH NAND

General Counsel –

Emerging Markets

Stephen Manzano

STEPHEN MANZANO

General Counsel –

Advanced Markets

Naveen Narayanan

NAVEEN NARAYANAN

Chief Human

Resources Officer

We are Transforming Healthcare. Transforming Lives!

Biocon Biologics is a unique, fully integrated leading global biosimilars player with established capabilities in the development, manufacturing and commercialization of high-quality biosimilars. Our 40-year legacy of being on the cutting edge of science has enabled us to simultaneously build global scale with a competitive cost structure. With a comprehensive portfolio of biosimilars, Biocon Biologics is transforming healthcare, transforming lives.

Share